Recruiting studies: Cataplexy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
Phase 2 · 18 location(s) · Takeda · NCT07633301 A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central
Phase 2/Phase 3 · 7 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07598708 A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Phase 2 · 52 location(s) · Takeda · NCT06952699 A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Phase 3 · 14 location(s) · Harmony Biosciences Management, Inc. · NCT07675135 A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Phase 3 · 22 location(s) · Alkermes, Inc. · NCT07455383 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168 Decreasing Nightmares in Adults With Narcolepsy
NA · 1 location(s) · University of Utah · NCT06383806 A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
Phase 3 · 25 location(s) · Takeda · NCT07363720

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.